Emily Rose, MD

Beth Israel Deaconess Medical Center
Boston, MA, United States

Internal Medicine Resident

Disclosure information not submitted.

Presentation(s):

• 0781: Rituximab Treated Patients with Hypogammaglobulinemia Are Less Likely to Seroconvert Following SARS-CoV-2 Vaccine Supplemental Dose

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time